Home/Filings/4/0001104659-23-008855
4//SEC Filing

Gelone Steven P. 4

Accession 0001104659-23-008855

CIK 0001641640other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 8:56 PM ET

Size

4.8 KB

Accession

0001104659-23-008855

Insider Transaction Report

Form 4
Period: 2023-01-29
Gelone Steven P.
Chief Development Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2023-01-29$1.50/sh140$21014,283 total
Footnotes (1)
  • [F1]These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.

Issuer

Nabriva Therapeutics plc

CIK 0001641640

Entity typeother

Related Parties

1
  • filerCIK 0001693064

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 8:56 PM ET
Size
4.8 KB